Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

38%

6 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (5)
P 1 (1)
P 2 (1)
P 3 (6)

Trial Status

Completed7
Recruiting4
Unknown2
Terminated1
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07520565Phase 3RecruitingPrimary

A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

NCT07194564Not ApplicableActive Not Recruiting

Acute Training Effect Assessment in Adolescent Idiopathic Scoliosis

NCT05473975CompletedPrimary

Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker

NCT06251505CompletedPrimary

Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyphosis

NCT06702657Not ApplicableNot Yet RecruitingPrimary

A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy

NCT04422366Phase 3Recruiting

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT04895020Phase 3Recruiting

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

NCT05372016Phase 3Completed

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05466383Not ApplicableRecruitingPrimary

Screening and Intervention for AIS in Haikou, Hainan Province, China

NCT05584332Phase 3Terminated

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05496361Not ApplicableCompletedPrimary

A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

NCT04425291Phase 3Completed

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05152329Unknown

Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers

NCT02905565Phase 2CompletedPrimary

NBP in Adult Patients With Acute Ischemic Stroke (AIS)

NCT03676101Phase 1Completed

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT03105063Not ApplicableUnknownPrimary

Evaluation of the AIIS Using Hip Ultrasound(AIISUS)

Showing all 16 trials

Research Network

Activity Timeline